Endogenous retroviruses as targets for antitumor immunity in renal cell cancer and other tumors
Human endogenous retroviruses (HERVs), remnants of ancient germ-line infections with exogenous retroviruses, are estimated to comprise up to 8% of human genome. Most HERVs have accumulated mutations and deletions that prevent their expression as an infectious virus. Nevertheless, a growing number of...
Main Authors: | Elena eCherkasova, Quinn eWeisman, Richard W. Childs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00243/full |
Similar Items
-
How Active Are Porcine Endogenous Retroviruses (PERVs)?
by: Joachim Denner
Published: (2016-08-01) -
Impacts of endogenous retroviruses on tumorigenesis, immunity, stem cells and research safety
by: Iyoko eKatoh
Published: (2014-03-01) -
Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
by: Annacarmen Petrizzo, et al.
Published: (2021-04-01) -
Nomenclature for endogenous retrovirus (ERV) loci
by: Robert J. Gifford, et al.
Published: (2018-08-01) -
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
by: Amaia Vergara Bermejo, et al.
Published: (2020-07-01)